TradingForProfitPro

JONSON & JONSON D1

看多
NYSE:JNJ   Johnson & Johnson
The prices of shares of pharmaceutical companies have dropped significantly since the beginning of autumn. Like many other stock market assets. Today, the Coronovirus situation is starting to worsen! The number of patients and deaths is increasing every day. And this is not surprising. Because the vacation season is over and the inhabitants of the whole planet have gone to study and work. Increasing contact between people will certainly increase the number of sick people. Also, the onset of the cold season will contribute to new diseases. That will give an opportunity for pharmaceutical companies to make good profits. Johnson & Johnson also released a new drug for psoriasis. And he is actively working in other branches of medicine.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。